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Background: Use of collagen membrane (CM) with xenograft and recombinant human platelet-derived
growth factor (rhPDGF) in guided bone regeneration (GBR) is debatable. The aim of this microcomputed
tomographic experiment was to assess the efficacy of using PDGF and xenograft (with or without CM) for
GBR around immediate implants with dehiscence defects.
Methods: Ten beagle dogs underwent atraumatic bilateral second and fourth premolar extractions
from both arches. A standardized dehiscence defect (6 · 3 mm) was created on the buccal bone and
immediate implants were placed in distal sockets in each site. Animals were randomly divided into three
groups: 1) group 1, xenograft with rhPDGF was placed and covered with CM; 2) group 2, xenograft with
rhPDGF was placed over the defects; and 3) group 3, four immediate implants were associated with dehis-
cence (controls). After 16 weeks, animals were sacrificed and jaw segments were assessed for buccal
bone thickness (BBT), buccal bone volume (BBV), vertical bone height (VBH), and bone-to-implant con-
tact (BIC) using microcomputed tomography.
Results: BBT was higher in group 2 (1.533 – 0.89 mm) than group 1 (0.745 – 0.322 mm) (P <0.001)
and group 3 (0.257 – 0.232 mm) (P <0.05). BBV was higher in group 2 (67.87 – 19.83 mm3) than
group 1 (42.47 – 6.78 mm3) (P <0.05) and group 3 (19.12 – 4.06 mm3) (P <0.001). VBH was higher
in group 2 (6.36 – 1.37 mm) than group 3 (0.00 – 0.00 mm) (P <0.001). VBH was higher in group 1
(3.91 – 2.68 mm) than group 3 (0.00 – 0.00 mm) (P <0.05). BIC was higher in group 2 (67.25% –
13.42%) than group 1 (36.25% – 12.78%) (P <0.05) and group 3 (30.25% – 7.27%) (P <0.01).
Conclusion: GBR around immediate implants with dehiscence defects using PDGF and xenograft alone
resulted in higher BBT, BBV, VBH, and BIC than when performed in combination with CM. J Periodontol
2013;84:371-378.
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I
t is well acknowledged that the buccal process of
alveolar bone is entirely composed of bundle bone
and is therefore more susceptible to undergo re-
sorption after tooth extraction compared to the lin-
gual/palatal process.1-8 Nevins et al.9 reported that
‡20% of the buccal process of alveolar bone un-
dergoes resorption within the first 12 weeks of tooth
loss, whereas studies by Schropp et al.7,8 reported
that nearly 66% of the alveolar bone undergoes re-
sorption within the first 3 months of tooth extraction.
Results from a recent histologic study4 on baboons
emphasized that the buccal bone receives an essen-
tial share of its vascular supply from the adjacent
interdental bone and not merely from the socket side
of the alveolus. This study4 also showed that extrac-
tion of multiple contiguous teeth is associated with
a more intense alveolar bone remodeling around
extraction sites because the interdental vascular
supply is compromised to a much larger extent
compared to when a single tooth is extracted. It has
been reported that immediate implant placement in
fresh extraction sites may prevent alveolar bone
remodeling in the short term;10,11 however, localized
osseous defects around immediate implants placed
in fresh extraction sites may present a challenge to
the clinician.12
Guided bone regeneration (GBR) using barrier
membranes has been applied in implant dentistry for
increasing the width and height of the alveolar ridge
in areas with insufficient bone.9-13 Various combina-
tions of resorbable membranes and bone grafts, such
as collagen membranes (CMs) with demineralized
freeze-dried bone allograft, CMs with deproteinized
bovine bone, and dermal matrix membranes with bio-
active glass have been used in GBR.14,15 Although
studies16,17 have reported that placement of a barrier
membrane over the bone grafts during GBR favors
new bone formation around immediate implants, the
contribution of resorbable membranes during GBR
using xenografts and growth factors is unclear.
Growth factors are polypeptide hormones that
regulate the cellular events associated with tissue
regeneration and repair.18-20 The platelet-derived
growth factor (PDGF) has been comprehensively as-
sessed with reference to periodontal regeneration.19-24
Studies19-24 have demonstrated that PDGF endorses
formation of new bone tissues around immediate
implants with periodontal bony defects in the pres-
ence, as well as absence, of barrier membranes. The
present study is based on the null hypothesis that
use of a resorbable barrier membrane during GBR
with PDGF and xenograft does not enhance the
buccal bone thickness (BBT), buccal bone volume
(BBV), vertical bone height (VBH), and bone-to-im-
plant contact (BIC) around immediate implants with
buccal dehiscence-type defects.
The present microcomputed tomographic analysis
aims to assess the efficacy of using PDGF and xeno-
graft (either with or without a CM) on GBR around
immediate implants with dehiscence-type defects
in a canine model.
MATERIALS AND METHODS
Ethical Considerations
The study was approved by the ethical committee at
the Engineer Abdullah Bugshan Research Chair for
Growth Factors and Bone Regeneration (GFBR),
King Saud University, Riyadh, Saudi Arabia. Pre-
operative animal care, all surgical procedures, and
postoperative management of the animals were
performed in accordance with the Animal Care
Guidelines of GFBR.
Study Animals
Ten female beagle dogs with a mean age and weight
of 19 – 1 months and 13.8 – 1.00 kg, respectively,
were used. The animals were kept in individual
cages and vaccinated against rabies and infectious
hepatitis.
The non-surgical and surgical procedures were
performed under general anesthesia§ (10 mg/kg body
weight).
Preoperative Management
During the housing period, the dogs underwent su-
pragingival scaling twice a week for 3 weeks using
an ultrasonic scaler.i Intramuscular amoxicillin¶ (25
mg/kg body weight) was administered 1 day before
surgery, followed by a second dose of the same an-
tibiotic# at the time of surgery.
Animal Grouping and Treatment of Dehiscence
Defects
The animals were randomly divided into three
groups (by picking a paper marked ‘‘group 1,’’
‘‘group 2,’’ or ‘‘group 3’’ from a brown bag). Animal
grouping was based on the methodology adopted
for the treatment of dehiscence defects: 1) group 1
(18 defects), in which xenograft** soaked in re-
combinant human (rh) PDGF-BB†† was placed over
the defects and covered with a CM;‡‡ 2) group 2 (18
defects), in which xenograft§§ was soaked in
rhPDGF-BBii and placed over the defects; and 3)
group 3 (four defects), in which four immediate im-
plants¶¶ were associated with dehiscence (controls,
no treatment). In group 1 and group 2, 0.5 mL of 0.3
§ Pfizer, New York, NY.
i NSK, Westborough, MA.
¶ Betamox LA, Norbrook Laboratory, Newry, County Down, Ireland.
# Betamox LA, Norbrook Laboratory.
** Laddec, OST Development, Clermont-Ferrand, France.
†† GEM 21S, Osteohealth, Shirley, NY.
‡‡ Mem-Lok, BioHorizons, Birmingham, AL.
§§ Laddec, OST Development.
ii GEM 21S, Osteohealth.
¶¶ Laser-Lok microchannels, BioHorizons, Birmingham, AL.
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mg/mL rhPDGF was delivered using the particulate
xenograft.##22
Surgical Protocol
After general anesthesia (as described above), ani-
malsweredraped,and thesurgical siteswereswabbed
with an antiseptic solution.*** Local anesthesia†††
was administered in the bilateral premolar regions of
both arches. Teeth (second premolar [P2] and fourth
premolar [P4]) were atraumatically extracted using
piezosurgery.‡‡‡ All buccal
and lingual/palatal bone was
sound with no dehiscence.
Using a sulcular incision (with
a no. 15 blade), full-thickness
buccal and lingual/palatal
flaps were raised to the mu-
cogingival junction, after
which a partial-thickness flap
was raised to allow passive
closure. Two vertical incisions
(one mesial and one distal)
were made. In each quadrant,
P2 and P4 were extracted. A
standardized hard acrylic
stent§§§ was used to create
a dehiscence bony defect (3 ·
6 mm) on the buccal surface
of the extraction socket (Fig.
1). This was followed by im-
mediate implantiii (3.8 · 10.5
mm) placement in the distal
extraction sockets (Fig. 1)
and assignment of this site
to one of the three groups.
The surgical wounds were





All animals received intra-
muscular (IM) injections of
amoxicillin### (25 mg/kg
body weight) every 8 hours
for 5 days. Analgesics****
(0.01 to 0.02 mg/kg, IM) were
administered immediately
after surgery and every 8
hours for the first 2 days after
surgery and then whenever
needed depending on the
presence of signs of pain by
the animal (such as rest-
lessness, unusual calmness,
or refusal to eat). Plaque
control procedures, using topical application of
a 0.2% chlorhexidine digluconate solution,†††† were
Figure 1.
A) Preoperative photograph; B) elevation of full-thickness mucoperiosteal flaps; C) placement of stent
on the buccal wall for creation of critical size defect; D) critical size defect (3 · 6 mm); E) placement
of notch (yellow arrow); F) immediate implant placement; G) adaptation of CM; H) placement of
xenograft; I) suturing; and J) 1-month follow-up photograph.
## Laddec, OST Development.
*** Purdue Fredrick Company, Stamford, CT.
††† Astra, Westborough, MA.
‡‡‡ Mectron, Piezosurgery, Columbus, OH.
§§§ Ellman International, Oceanside, NY.
iii Laser-Lok microchannels, BioHorizons.
¶¶¶ Gore-Tex, W.L. Gore & Associates, Flagstaff, AZ.
### Buprenorphine, SR Veterinary Technologies, Windsor, CO.
**** GUM, Sunstar GUM, Chicago, IL.
†††† Gore-Tex, W.L. Gore & Associates.
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performed twice weekly for 4 months after surgery.
Sutures‡‡‡‡ were removed after 10 days of surgery,
and the animals were kept on a soft diet throughout
the study period.
After 4 months, the animals were sacrificed with an
intravenous overdose of 3% sodium pentobarbital.§§§§
Hard-Tissue Sectioning and Microcomputed
Tomography
The jaw segments containing the dental implants and
associated mesial and distal tooth structures were
removed en bloc using an electric sawiiii and fixed
in 10% neutral formalin solution.
Amicrocomputed tomography (microCT) scanner¶¶¶¶
was used to evaluate the BBT, BBV, VBH, and BIC
around immediate implants. The x-ray generator of
the microCT was operated at an accelerated potential
of 101 kV with a beam current of 96 mA using an
aluminum filter with a resolution of 37.41-mmpixels.
The BBT wasmeasured at every 1-mm level starting
from the alveolar crest to the base of the defect (Figs.
2A and 2B). The BBV was measured as described in
a recent study.25 In the adjacent teeth, VBH was
measured via linear measurements (in millimeters)
that extended from the crest of the implant to the
apical notch (Fig. 2C). For BIC measurement, the
total surface area of the region of interest (ROI) and
the subset of the ROI surface that was intersected by
binarized bone objects was measured via an analysis
software.3,26 The parameter thus measured was
called ‘‘intersection surface’’ that corresponded to
BIC. The BIC was calculated (at ·100 magnification)
as the percentage of implant surface in contact with
the bone through the whole perimeter of the implant.3,26
Statistical Analyses
Statistical analyses were performed using a statisti-
cal software.#### The power of the present study was
95% (common standard deviation of 1 mm and a =
0.05). One-way analysis of variance was used to
determine the differences in means of the BBT, BBV,
VBH, and BIC among the groups. P values 0.05 were




The mean BBT was significantly higher around de-
hiscence defects in group 2 (1.533 – 0.89 mm)
compared to that in group 1 (0.745 – 0.322 mm)
(P <0.01) and group 3 (0.257 – 0.232 mm) (P <0.05).
There was no significant difference in the BBT
Figure 2.
Measurement of BBT (yellow arrows) around immediate implants: A)
axial view andB) sagittal view.C)Measurement of BBT (a) and VBH (b).
‡‡‡‡ W.A. Butler Company, Dublin, OH.
§§§§ SP 1600, Leica, Bannockburn, IL.
iiii SkyScan 1172, CT-Analyser v.1.11.4.2+, Skyscan, Kontich, Belgium.
¶¶¶¶ nQuery Advisor v.7.0, Statistical Solutions, Saugus, MA.
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between sites in group 1 (0.257 – 0.232 mm) com-
pared to group 3 (control group) (Figs. 3A, 4, and 5).
BBV
The mean BBV was significantly higher around de-
hiscence defects in group 2 (67.87 – 19.83 mm3)
compared to group 1 (42.47 – 6.78 mm3) (P <0.05)
and group 3 (19.12 – 4.06 mm3) (P <0.001). There
was no significant difference in the mean BBV be-
tween group 1 (42.47 – 6.78 mm3) and group 3
(19.12 – 4.06 mm3) (Figs. 3B, 4, and 5).
VBH
The mean VBH was significantly higher around de-
hiscence defects in group 2 (6.36 – 1.37 mm)
compared to the control group (group 3) (0.00 – 0.00
mm) (P <0.001). The mean VBH was significantly
higher around dehiscence defects in group 1 (3.91 –
2.68 mm) compared to the control group (group 3)
(0.00 – 0.00 mm) (P <0.05). VBH was significantly
higher in group 1 (3.91 – 2.68 mm) compared to
group 3 (0.00 – 0.00 mm) (P <0.05). There was no
significant difference in the VBH between group 1
Figure 3.
A)A graphic representation of the BBTaround immediate implantswith dehiscence in sites in group1 (purple circle: PDGF+ xenograft+CM), group2 (green
circle: PDGF + xenograft), and group 3 (orange circle: control/no treatment). BBTwas significantly higher among sites in group 2 compared to sites in group 1
(P <0.01) and group 3 (P <0.05). *P <0.05; †P <0.01. B) A graphic representation of the BBV around immediate implants with dehiscence among
sites in group 1 (purple circle: PDGF + xenograft + CM), group 2 (green circle: PDGF + xenograft) and group 3 (orange circle: control/no treatment). BBV was
significantly higher among sites in group 2 compared to those in group 1 (P <0.05) and group 3 (P <0.001). *P <0.05; ‡P <0.001. C) A graphic
representation of the VBHaround immediate implants with dehiscence among sites in group 1 (purple circle: PDGF + xenograft+ CM), group 2 (green circle:
PDGF + xenograft), and group 3 (orange circle: control/no treatment). VBH was significantly higher among sites in group 2 compared to those in group
1 (P <0.05) and group 3 (P <0.001). *P <0.05; ‡P <0.001. D) A graphic representation of the BIC around immediate implants with dehiscence
among sites in group 1 (purple circle: PDGF + xenograft + CM), group 2 (green circle: PDGF + xenograft), and group 3 (orange circle: control/no treatment).
BIC was significantly higher among sites in group 2 compared to those in group 1 (P <0.05) and group 3 (P <0.01). *P <0.05; †P <0.01.
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(3.91 – 2.68 mm) and group 2 (6.36 – 1.37 mm)
(Figs. 3C and 4).
BIC
The mean BIC was significantly higher around de-
hiscence defects in group 2 (67.25% – 13.42%)
compared to that in group 1 (36.25% – 12.78%)
(P <0.05) and group 3 (30.25% – 7.27%) (P <0.01)
(Figs. 3D and 4). There was no significant difference
in the mean BIC among sites in group 1 (36.25% –
12.78%) and group 3 (30.25% – 7.27%) (Figs. 3D, 4,
and 5).
Therewasnosignificant difference in theBBT,BBV,
VBH, and BIC on the lingual surface of the implants
among the three groups.
DISCUSSION
The present microcomputed tomographic results
demonstrated that GBR around immediate implants
with buccal dehiscence-type defects was enhanced
when treated merely with
xenograft and PDGF com-
pared to when a CM was
placed over the xenograft
soaked in PDGF. These re-
sults are in accordance with
studies27-32 that demonstrated
that growth factors exhibit
the potential to regenerate
bone in dehiscence-type de-
fects around implants. It has
been hypothesized that the
gel-like consistency of growth
factors provides a space-
making potential to the
growth factor, and simulta-
neous use of graft material
may hinder the collapse of
the flap into the bone defect
during the early healing
phase.32 Likewise, in a recent
systematic review,29 the au-
thors reported that treatment
of periodontal osseous de-
fects with enamel matrix
derivative (an amelogenin-
rich growth factor) is as
effective as when resorbable
membranes are used during
GBR. Simion et al.16,18 hy-
pothesized that barrier
membranes obstruct the che-
motactic effect of the growth
factor on periosteal pluri-
potential mesenchymal cells.
Similar results were reported
by Kanou et al.33 This may be an explanation for
our results that demonstrated a higher BBT, BBV,
and BIC around dehiscence treated with PDGF and
xenograft alone compared to those covered with
CM after placement of PDGF and xenograft over
the defect. However, additional studies are war-
ranted to investigate the influence of barrier mem-
branes on the periosteal pluripotential mesenchymal
cells.
Several studies18-22 have shown that PDGF en-
hances periodontal regeneration by accelerating
events, such as cellular chemoattraction, differentia-
tion, and proliferation. Mott et al.34 used fluorescence
effects to investigate the effect of bone graft soaked
in PDGF on osteoblastic proliferation around rat cal-
varia defects. The results demonstrated that use of
bone grafts soaked in PDGF significantly enhanced
osteoblastic proliferation in the defect sites com-
pared to sites merely treated with bone graft.34 In
another study, Sanchez-Fernandez et al.27 tested the
Figure 4.
A through C) A series of reconstructed axial microCT images illustrating the thickness of the newly formed
buccal bone (green) around immediate implantswith dehiscence defects in groups 1 through 3.DthroughF)
A series of reconstructed sagittal microCT images illustrating the vertical height of the newly formed buccal
bone around immediate implants with dehiscence defects in groups 1 through 3.
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hypothesis that osteoclasts can regulate the che-
motaxis of osteoblasts. The results demonstrated
that mature osteoclasts produce factors including
the PDGF that attract osteoblasts toward sites with
osseous defects, thereby promoting new bone re-
generation in the target tissues.27 Similar results
were reported by Park et al.35 Likewise, Howes
et al.36 reported that PDGF enhances demineralized
bone matrix-induced cartilage and bone formation.
The present microCT results support these stud-
ies27,35,36 because dehiscence defects treated
merely with xenograft and PDGF displayed signifi-
cantly more osseous regeneration compared to the
defects treated with xenograft, PDGF, and CM. This
reflects that the osteopromotive effects of PDGF
are significant enough to induce new bone forma-
tion, and the contribution of a CM in this regard is
redundant.
According to the present results, VBH and BICwere
significantly higher around immediate implantswhere
dehiscence sites were treated merely with xenograft
and PDGF compared to sites covered with a CM after
placement of PDGF and xenograft. A possible ex-
planation in this regard may be extracted from a his-
tologic study37 inwhich theauthorsdemonstrated that
CMs have a short half-life and are susceptible to re-
sorption. Early resorption of a CM may contribute to
impeding the osteogenic activity taking place in the
space beneath the membrane.
CONCLUSION
Within the limits of the pres-
ent microCT experiment, it is
concluded that GBR around
immediate implants with de-
hiscence defects using PDGF
and xenograft alone resulted
in higher BBT, BBV, VBH, and
BIC than when performed in
combination with a CM.
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